Apyx Medical Corporation to Release Third Quarter of Fiscal Year 2026 Financial Results on November 5, 2026By Jada Hoffman|2026-10-22T09:18:12-04:00October 22, 2026|
Apyx Medical Corporation to Participate in Upcoming Investor ConferencesBy Jada Hoffman|2026-10-21T09:46:54-04:00October 21, 2026|
Apyx Medical Announces New Clinical Study Demonstrating Renuvion®’s Impact on Skin QualityBy Jada Hoffman|2026-09-28T20:12:53-04:00September 29, 2026|
Apyx Medical Corporation Reports Second Quarter 2026 Financial ResultsBy Jada Hoffman|2026-08-06T11:51:21-04:00August 6, 2026|
Apyx Medical Corporation to Participate in the Canaccord Genuity 46th Annual Growth ConferenceBy Jada Hoffman|2026-08-26T16:06:28-04:00July 28, 2026|
Body by Apyx Takes Center Stage at Miami Swim Week Showcasing Real Patient Transformations and Confidence on the RunwayBy Jada Hoffman|2026-08-26T14:39:26-04:00May 27, 2026|
Apyx Medical Corporation Announces Retrospective Clinical Publication Evaluating Clinical Benefit of Renuvion® Used in Combination with LiposuctionBy Jada Hoffman|2026-05-13T16:43:11-04:00May 14, 2026|
Apyx Medical Corporation Receives Expanded FDA 510(k) Clearance Adding Power Liposuction Capability to AYON Body Contouring System™By Jada Hoffman|2026-05-08T14:46:04-04:00May 11, 2026|
Apyx Medical Corporation Reports First Quarter 2026 Financial ResultsBy Jada Hoffman|2026-05-06T17:28:46-04:00May 7, 2026|
Apyx Medical Corporation Announces Approval and Commercial Launch of Apyx One Console and Single-Use Handpieces for Cosmetic Surgical Procedures in South KoreaBy Jada Hoffman|2026-05-06T17:24:41-04:00December 3, 2025|
